Injury-transduced SerpinOLs modulate neuroinflammation and glial activation in the diseased and non-diseased CNS

Yan Wang1,2, Meina Zhu1,2, Joohyun Park1,2

  • 1Department of Neurology, School of Medicine, University of California, Davis.

Insights

Oligodendrocytes (OLs) change into SerpinOLs upon CNS injury, secreting SERPINA3N. These SerpinOLs worsen neuroinflammation and glial activation, impacting brain health.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Oligodendroglial dysfunction is prevalent in central nervous system (CNS) diseases and injuries.
  • The precise molecular and functional responses of oligodendroglia to CNS pathologies are not well understood.

Purpose of the Study:

  • To investigate the molecular and functional changes in oligodendrocytes (OLs) in response to CNS pathologies.
  • To identify specific molecular pathways and cell states involved in oligodendrocyte responses to injury and disease.

Main Methods:

  • Analysis of oligodendrocyte responses in various CNS disease and injury models.
  • Molecular profiling of oligodendrocytes under different conditions.
  • Investigation of the functional consequences of oligodendrocyte changes on neuroinflammation and glial activation.

Main Results:

  • Oligodendrocytes (OLs) dysregulate serine protease inhibitor clade A member 3N (SERPINA3N) in response to demyelinating diseases.
  • Homeostatic OLs transition to SerpinOLs under diverse conditions including stroke, neurodegeneration, and aging.
  • Oligodendrocyte damage/injury, independent of neuroinflammation, triggers SerpinOL transition.
  • SerpinOLs exhibit inflammatory and immune regulatory signatures, with activated STAT3 signaling.
  • SerpinOLs amplify neuroinflammation and promote pro-inflammatory glial activation.

Conclusions:

  • SerpinOLs represent a common population of injury-transduced OLs in the CNS.
  • These cells amplify neuroinflammation and glial activation via SERPINA3N secretion.
  • Findings reveal a myelination-independent role for OLs in regulating CNS pathophysiology.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
565